Zarodex Therapeutics Limited, Cambridge
| About | |
|---|---|
| Name: Zarodex Therapeutics Limited | |
| Number: 10885695 | |
| Incorporation date: 2017-07-26 | |
| End of financial year: 30 September |
| Address: |
Pem, Salisbury House Station Road Cambridge CB1 2LA |
| SIC code: |
72110 - Research and experimental development on biotechnology |
| Nature of control: |
50,01-75% shares 50,01-75% voting rights right to appoint and remove directors |
| Nature of control: |
50,01-75% shares 50,01-75% voting rights right to appoint and remove directors |
| Date of Accounts | 2018-09-30 | 2019-09-30 | 2020-09-30 |
| Current Assets | 1,022,544 | 1,330,854 | 1,611,554 |
| Total Assets Less Current Liabilities | -337,347 | -985,218 | -2,973,535 |
Zarodex Therapeutics Limited was formally closed on 2024-03-01.
Zarodex Therapeutics was a private limited company that was located at Pem, Salisbury House, Station Road, Cambridge, CB1 2LA. Its full net worth was estimated to be around 0 pounds, while the fixed assets the company owned totalled up to 0 pounds. The company (officially started on 2017-07-26) was run by 3 directors.
Director Kate B. who was appointed on 28 February 2018.
Director Houman A. who was appointed on 26 July 2017.
Director Duncan M. who was appointed on 26 July 2017.
The company was officially classified as "research and experimental development on biotechnology" (72110).
The latest confirmation statement was filed on 2022-06-30 and last time the annual accounts were filed was on 30 September 2020.
| Type | Free download | |
|---|---|---|
| GAZ2 |
Final Gazette dissolved via compulsory strike-off filed on: 1st, March 2024 | gazette |
Free Download
(1 page)
|